Key result
In silico analysis suggests the GNE V727M mutation impairs protein stability and alters MYC interaction.
Why the study?
The GNE p.V727M mutation is an ethnic founder mutation in Indian patients with hereditary inclusion body myopathy, but its underlying pathogenic mechanisms remain largely unknown.
In silico analysis suggests the V727M founder mutation in GNE alters interaction with MYC, potentially explaining its role in hereditary inclusion body myopathy.
Answers are grounded in this paper and cite their sources.
In silico predictions for GNE V727M may aid variant classification; leaves open functional validation before clinical use.
GNE gene-specific c.2179G>A(p.V727M) is a key alteration reported in patients with hereditary inclusion body myopathy (HIBM) and represents an ethnic founder mutation in the Indian cohort. However, the underlying role of this mutation in pathogenesis remains largely unknown. Thus, in this study, we aimed to access possible mechanisms of V727M mutation that could be leading to myopathy. We evaluated various in silico tools to predict the effect of this mutation on pathogenicity, structural or possible interactions, that could induce myopathy. Our results propose that V727M mutation could induce deleterious effects or pathogenicity and affect the stability of GNE protein. Analysis of differential genes reported in the V727 mutant case suggests that it can affect GNE protein interaction with Myc-proto-oncogene (MYC) transcription factor. Our in silico analysis also suggests a possible interaction between GNE ManNac-kinase domain with MYC protein at the C-terminal DNA-binding domain. MYC targets reported in skeletal muscles via ChIP-seq suggest that it plays a key role in regulating the expression of many genes reported differentially expressed in V727M-mutated HIBMs. We conclude that V727M mutation could alter the interaction of GNE with MYC thereby altering transcription of sialyltransferase and neuromuscular genes, thus understanding these effects could pave the way for developing effective therapies against HIBM.
No takes yet. Share an insight, caveat, or question.
Attri et al. (2021) studied Hereditary inclusion body myopathy (HIBM). GNE gene-specific c.2179G>A(p.V727M) mutation was evaluated on Pathogenicity, structural stability, and protein interactions. In silico analysis suggests the V727M mutation in GNE induces deleterious effects on protein stability and alters its interaction with the MYC transcription factor.
Synapse has enriched 10 related papers. Consider them for comparative context: